Company Filing History:
4 out of 15 
1 out of 13 
1 out of 93 
Years Active: 2024-2025
Title: Yong-Gyu Son: Innovator in Bispecific Antibody Research
Introduction
Yong-Gyu Son is a prominent inventor based in Seongnam-si, South Korea, known for his significant contributions to the field of biopharmaceuticals. With a total of four registered patents, he is at the forefront of innovative research, particularly in developing bispecific antibodies that aim to enhance cancer treatment.
Latest Patents
Yong-Gyu Son's recent patents include groundbreaking work on bispecific antibodies. One of his latest inventions is the "Anti-HER2/anti-4-1BB bispecific antibody and use thereof." This invention details a bispecific antibody along with a pharmaceutical composition and a method for treating and/or preventing cancer. Another notable patent is the "Anti-PD-L1/anti-4-1BB bispecific antibodies and uses thereof," which presents an innovative bispecific antibody designed to effectively block the interactions between PD-L1 and its receptor PD-1, as well as between 4-1BB and its ligand. This antibody is characterized by its high binding affinity to both PD-L1 and 4-1BB proteins.
Career Highlights
Yong-Gyu Son has worked with notable companies, including Abl Bio Inc. and I-Mab Biopharma US Limited. His experience in these organizations has contributed to his expertise and ability to push the boundaries of antibody research, particularly in the context of cancer therapies.
Collaborations
Throughout his career, Yong-Gyu Son has collaborated with talented individuals, including Hyejin Chung and Yangsoon Lee. These partnerships have enhanced his innovative capabilities and have been instrumental in driving forward the projects he has undertaken.
Conclusion
Yong-Gyu Son's work in developing bispecific antibodies has the potential to significantly impact cancer treatment methodologies. His patents reflect a commitment to advancing medical science and demonstrate the critical role of innovation in combating disease. With a solid background and fruitful collaborations, Yong-Gyu Son is a notable figure to watch in the evolving field of biopharmaceutical research.